Literature DB >> 31927800

Morbidity and Mortality Following Endovascular Repair of Abdominal Aortic Aneurysms in the Elderly.

Daniel Silverberg1,2, Ahmad Abu Rmeileh1,2, Daniel Raskin3,2, Uri Rimon3,2, Moshe Halak1,2.   

Abstract

BACKGROUND: Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA) is associated with decreased perioperative morbidity and mortality.
OBJECTIVES: To report the outcomes of EVAR among patients older than 80 years of age.
METHODS: In this retrospective study, we reviewed patients older than 80 years of age who underwent elective EVAR at our institution between 2007 and 2017. The demographics, perioperative morbidity and mortality, and long-term results are reported.
RESULTS: During the study period, 444 patients underwent elective EVAR for AAAs. Among them 128 patients (29%) were > 80 years of age. Mean age was 84 ± 3.4 (range 80-96) years, and 110 patients (86%) were male. The EVAR was technically successful in 127 patients (99%) and there were intraoperative mortalities. Within 30 days of the surgery, nine patients (7%) died. Major and minor adverse events occurred in 26 (20%) and 59 (46%) patients, respectively. Factors associated with increased risk of perioperative morbidity and mortality included chronic kidney disease, peripheral artery disease, and the existence of three or more co-morbidities.
CONCLUSIONS: EVAR in the elderly can be performed with a high rate of success; however, it is associated with a substantial rate of morbidity and mortality, particularly when patients present with multiple co-morbidities. When performing EVAR in this population group, the risk of rupture must be considered opposed to the life expectancy of these patients and the risk of perioperative morbidity and mortality.

Entities:  

Mesh:

Year:  2020        PMID: 31927800

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  1 in total

1.  Overview of screening eligibility in patients undergoing ruptured AAA repair from 2003 to 2019 in the Vascular Quality Initiative.

Authors:  Lucas Mota; Christina L Marcaccio; Kirsten D Dansey; Livia E V M de Guerre; Thomas F X O'Donnell; Peter A Soden; Sara L Zettervall; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2021-10-22       Impact factor: 4.268

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.